Valproate-Induced Hyperammonemic Encephalopathy
Valproate-induced hyperammonemic encephalopathy (VHE), predisposing causes, clinical, laboratory, and EEG findings, and therapy are reviewed from the Hospital del Mar, Barcelona, Spain.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2006-07-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1133 |
Similar Items
-
Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01) -
Valproate-Induced Encephalopathy
by: J Gordon Millichap
Published: (2000-01-01) -
Valproate Associated Hyperammonemic Encephalopathy
by: Wadzinski, Jim, et al.
Published: (2007) -
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
by: Laura María Palomino Pérez, et al.
Published: (2020-09-01) -
Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
by: Vivekanandan S, et al.
Published: (2010-01-01)